These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7525425)

  • 1. Natural killer cell activity in stage I endometrial carcinoma: correlation with nuclear grading, myometrial invasion, and immunoreactivity of proliferating cell nuclear antigen.
    Garzetti GG; Ciavattini A; Goteri G; Tranquilli AL; Muzzioli M; Fabris N; De Nictolis M; Romanini C
    Gynecol Oncol; 1994 Oct; 55(1):111-4. PubMed ID: 7525425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferating cell nuclear antigen in endometrial carcinoma: pretreatment identification of high-risk patients.
    Garzetti GG; Ciavattini A; Goteri G; De Nictolis M; Romanini C
    Gynecol Oncol; 1996 Apr; 61(1):16-21. PubMed ID: 8626110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
    Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
    Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIB 1 immunostaining in stage I squamous cervical carcinoma: relationship with natural killer cell activity.
    Garzetti GG; Ciavattini A; Lucarini G; Goteri G; de Nictolis M; Muzzioli M; Fabris N; Romanini C; Biagini G
    Gynecol Oncol; 1995 Jul; 58(1):28-33. PubMed ID: 7789886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of proliferating cell nuclear antigen (PCNA) index and microvessel density (MVD) in endometrial carcinoma].
    Xiao L; Tang LD
    Ai Zheng; 2005 Jan; 24(1):19-22. PubMed ID: 15642194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability of magnetic resonance imaging in assessing myometrial invasion absence in endometrial carcinoma.
    Suh DS; Kim JK; Kim KR; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    Acta Obstet Gynecol Scand; 2009; 88(9):990-3. PubMed ID: 19636979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of D&C and hysterectomy pathologic findings in endometrial cancer patients.
    Wang X; Huang Z; Di W; Lin Q
    Arch Gynecol Obstet; 2005 Jul; 272(2):136-41. PubMed ID: 15666177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of final histology in patients with endometrial cancer.
    Frumovitz M; Singh DK; Meyer L; Smith DH; Wertheim I; Resnik E; Bodurka DC
    Gynecol Oncol; 2004 Dec; 95(3):463-8. PubMed ID: 15581947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma.
    Ismiil ND; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Thomas G; Ackerman I; Covens A; Khalifa MA
    Int J Gynecol Pathol; 2007 Jul; 26(3):278-83. PubMed ID: 17581412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CaMKIV expression is associated with clinical stage and PCNA-labeling index in endometrial carcinoma.
    Shang S; Takai N; Nishida M; Miyazaki T; Nasu K; Miyakawa I
    Int J Mol Med; 2003 Feb; 11(2):181-6. PubMed ID: 12525874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial carcinoma: results of primary surgery on FIGO stages Ia-Ic and predictive value of histopathological parameters.
    Lindahl B; Einarsdottir M; Iosif C; Ranstam J; Willén R
    Anticancer Res; 1997; 17(3C):2297-302. PubMed ID: 9216705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
    Ismiil N; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Ackerman I; Thomas G; Covens A; Khalifa MA
    Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphologic studies of endometrial cancer for biological assessment of nuclear grading].
    Köhler U
    Zentralbl Gynakol; 1991; 113(18):995-1003. PubMed ID: 1750299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma.
    Soeda S; Nakamura N; Ozeki T; Nishiyama H; Hojo H; Yamada H; Abe M; Sato A
    Gynecol Oncol; 2008 Apr; 109(1):122-8. PubMed ID: 18289648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proliferative activity of normal endometrial cells, endometrial hyperplasia cells and endometrial cancer cells using the monoclonal antibody to PCNA].
    Hareyama H
    Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1427-1. PubMed ID: 7705752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging in endometrial carcinoma as a diagnostic tool for the absence of myometrial invasion.
    Nakao Y; Yokoyama M; Hara K; Koyamatsu Y; Yasunaga M; Araki Y; Watanabe Y; Iwasaka T
    Gynecol Oncol; 2006 Aug; 102(2):343-7. PubMed ID: 16469365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of 2009 FIGO staging system on the diagnostic value of preoperative MRI staging of endometrial carcinoma].
    Yu XD; Ouyang H; Lin M; Zhou CW; Zhang R
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):692-6. PubMed ID: 22340052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multivariate analysis of assessment of myometrial invasion of endometrial carcinoma by magnetic resonance imaging.
    Atsukawa H; Sasaki H; Tada S
    Gynecol Oncol; 1994 Sep; 54(3):298-306. PubMed ID: 8088606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion.
    Sakuragi N; Nishiya M; Ikeda K; Ohkouch T; Furth EE; Hareyama H; Satoh C; Fujimoto S
    Gynecol Oncol; 1994 May; 53(2):183-9. PubMed ID: 8188077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.